HL7 Study Data Standards Project Crystal Allard CDER Office of Computational Science Food and Drug Administration February 13,

Slides:



Advertisements
Similar presentations
XML in Pharma – Weve Done SPL, Whats Next? SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES PHILADELPHIA, PA. FEBRUARY 2006.
Advertisements

HL7 Quality Reporting Document Architecture DSTU
HL7 January Working Group Meeting
RPS 2 Project Update Mary Ann Slack, FDA Presentation to HL7 RCRIM January 12, 2009.
Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.
CDISC Content to Message HL7 Development Overview Jason Rock
Clinical Genomics Sub-team Sub-team is one of three that evolved out of the DIA Pharmacogenomics Standards Workshop. Workshop was product of collaborative.
Managing and Analyzing Clinical Data
Update on CDISC Terminology Activities RCRIM Vocab Session (Q4) 14 January 2009, Orlando Bron Kisler (CDISC)
What’s New with CDISC Wayne R. Kubick CDISC CTO.
The Importance of CDASH
SEND Standard for the Exchange of Nonclinical Data
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting January 23, 2012.
Interoperability Framework Overview March 24, 2010 Presented by: Douglas Fridsma, MD, PhD Acting Director, Office of Interoperability & Standards ONC HIT.
EsMD Harmonization WG Meeting Wednesday, June 13 th, 2012.
CDER IND/NDA Reviews Guidance, The Common Technical Document and Good Review Practice John K. Leighton, Ph.D., DABT CDER/FDA.
Unique Device Identification (UDI): Implementation and Adoption Leslie M Tompkins, PhD FDA, Center for Devices and Radiological Health UDI Lead, Standards.
Requirements for Standardized Study Data: Update on Guidance Ron Fitzmartin, PhD, MBA Data Standards Program Office of Strategic Programs Center for Drug.
Riki Merrick, APHL Anna Orlova, PhD, PHDSC Lise Stevens, FDA Nikolay Lipskiy, MD, DrPH, MBA – CDC CSTE Conference June 5 th, 2012 The findings and conclusions.
Clinical Oncology Patient Transfer Summary Ballot Development Spring Ballot Clinical Oncology Treatment Plan and Summary, Release 1 Ballot for May 2013.
1CDISC 2002 RCRIM – Standard Domains Agenda NCI Presentation Standard Domains Working Group Goals Introduction to FDA Information Model (FIM) Discussion:
 BRIDG R3.0.2 was released in August 2010  The BRIDG Model passed the initial ISO Joint Initiative Council ballot as a Draft International Standard (DIS)
1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
Standards Analysis Summary vMR – Pros Designed for computability Compact Wire Format Aligned with HeD Efforts – Cons Limited Vendor Adoption thus far Represents.
1 RCRIM Vocab-BRIDG Session Wednesday, Session Q2 19 September 2007.
EHR System (EHR-S) Functional Requirements Implementation Guide: Laboratory Results Interface (LRI) Kickoff March 3 rd,
Interoperability Framework Overview Health Information Technology (HIT) Standards Committee June 24, 2010 Presented by: Douglas Fridsma, MD, PhD Acting.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting March 12, 2012.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 15, 2011.
Data Segmentation for Privacy Agenda All-hands Workgroup Meeting May 9, 2012.
Dave Iberson-Hurst CDISC VP Technical Strategy
Overview of CDISC standards and use cases along the E2E data management process Dr. Philippe Verplancke ESUG Marlow, UK 27 May 2009.
Kopenhagen, 22 April 2008 German CDISC User Group.
Transition of Care Reference Implementation & Pilots Kick-Off May 31, 2011.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
CDISC©2009 February CDISC INTRAchange Carey Smoak Device Team Leader Li Zheng Submission Data Standards Team Member Thurday, April 2, 2009.
Data Provenance Community Meeting November 6, 2014.
S&I PUBLIC HEALTH REPORTING INITIATIVE: DEVELOPING OF A TEAMING APPROACH S&I Public Health Reporting Initiative Nikolay Lipskiy, MD, DrPH, Co-Lead September,
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 1, 2011.
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Data Provenance Tiger Team May 9 th, 2014 Johnathan Coleman Johnathan Coleman - Initiative Coordinator Lynette ElliottLynette Elliott – Tiger Team Support.
CDISC Update December 2007 / January 2008 Pierre-Yves Lastic, PhD CDISC Board of Directors & E3C February 5, Paris.
S&I Public Health Education Series: Data Provenance July 9th, 2014 Johnathan Coleman Initiative Coordinator – Data Provenance ONC/OCPO/OST (CTR)
CDISC User Group in Deutschland/Japan Hajime Shimizu (nickname: Akiba) CDISC Japan User Group introduction to team activity.
Interchange vs Interoperability Main Entry: in·ter·op·er·a·bil·i·ty : ability of a system... to use the parts or equipment of another system Source: Merriam-Webster.
Public Health Reporting Initiative October 31, 2012.
The Patient Choice Project Project Kickoff December 14 th, 2015.
Electronic Submission of Medical Documentation (esMD)
CDISC – 17/12/2012 Carine Javierre Nathalie SABIN.
1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.
Standards & Interoperability (S&I) Structured Data Capture (SDC) FHIR Profile IG SWG.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 29, 2011.
Public Health Reporting Initiative November 14, 2012 Dial in: ; #
Standards Analysis Summary vMR – Pros Designed for computability Compact Wire Format Aligned with HeD Efforts – Cons Limited Vendor Adoption thus far Represents.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting February 13, 2012.
CDA Overview HL7 CDA IHE Meeting, February 5, 2002 Slides from Liora Alschuler, alschuler.spinosa Co-chair HL7.
BRIDG Update RCRIM Working Group Meeting Rio de Janeiro 17 May 2010 Julie Evans Senior Director, Technical Services, CDISC Wendy Ver Hoef Senior Analyst,
DIA Electronic Submissions Meeting Olga Alfieri 26 April 2016
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting September 12, 2011.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting July 18, 2011.
Submission Standards: The Big Picture Gary G. Walker Associate Director, Programming Standards, Global Data Solutions, Global Data Management.
ISO/HL Specification: Individual Case Safety Report (ICSR) Release 2 Lise Stevens Data Standards Project Manager FDA CBER/ADRM Bioinformatics Support.
Dave Iberson-Hurst CDISC VP Technical Strategy
Freundschaft Konferenz
CAC Meeting Tuesday, 21 June, CAC Meeting Tuesday, 21 June, 2017.
Why a Common Protocol Template?
Presentation transcript:

HL7 Study Data Standards Project Crystal Allard CDER Office of Computational Science Food and Drug Administration February 13, 2013

HL7 Study Data Standards Development Project An FDA-sponsored project within HL7 to harmonize CDISC study data content standards with HL7 v3 exchange standards FDA continues to hear from stakeholders that harmonization of standards across SDOs is important –This is one example

HL7 Study Data Standards Project Three related standards: –Study Design Structured Document (Protocol; what will be done?) –Study Participation (Who is involved?) –Subject Data Implementation Guide (I.G.) for CDA Release 2 (What was observed?) All three designed to transport existing CDISC content and additional high-level FDA study information exchange requirements (captured as storyboards or scenarios) All three support exchange of “round” hierarchical, multi- relational data

CDER’s Position on the HL7 Study Data Standards Project This is a Data Standards Research and Development (R&D) Activity No policy decisions have been made regarding adoption or implementation Position statement posted publicly on fda.gov – Requirements/ElectronicSubmissions/ucm htmhttp:// Requirements/ElectronicSubmissions/ucm htm

CDER Position Ongoing and increased CDER support for CDISC standards for study data content –2004: SDTM –2011: SEND Currently, CDER supports the submission of CDISC content using SAS Transport File (XPT) v5 exchange format –Limitations of this file format, and desire to move away from this format HL7 v3 XML exchange standard is a promising alternative to replace XPT v5.

Proof of Concept CDER conducting a proof of concept to test HL7 Study Data Standards (R&D activity) –In parallel with ongoing robust CDISC implementation efforts and Therapeutic Area (TA) standards development Incremental Testing: –Phase 1: Patient Narrative / Clinical Investigator Info (1572) –Phase 2: Structured Protocol –Phase 3: Subject Data Testing will include opportunity for interested stakeholders to participate –Open and transparent –Through HL7/RCRIM “Stage 2” project team Bi-weekly meetings, Wednesday 11am ET Crystal Allard, PM

HL7 Study Data: Proof of Concept Phase 1 Patient Narratives Clinical Investigator (FDA Form 1572) Phase 2 Structured Protocol Phase 3 Subject Data today

Phase 1: Current Status FDA Form 1572 (Clinical Investigator Information) and related information –Testing Complete –Test Report Complete Feb 2013 –Operational Pilot Project being planned Patient Narrative –Testing Nearly Done –Expect Test Report Q2 2013

Phase 2: Current Status Study Protocol content, as defined by ICH E6 guideline and CDISC SDTM Trial Design domains Testing initiated Sept 2012 –Draft Study Design S.D. Implementation Guide complete for clinical and nonclinical protocols; shared Nov 2012 with Stage 2 team for comment –Developed data entry tool, data visualization tool for testing –Expect completion of testing Q3 2013

Phase 2: Study Design Structured Document Study Protocol content, as defined by ICH E6 guideline and CDISC SDTM Trial Design domains “SPL” for Protocols Testing initiated Sept 2012 –Draft Study Design S.D. Implementation Guide complete –Shared Nov 2012 with Stage II team for comment –Developed data entry tool, data visualization tool for testing (we will review today) –Expect completion of testing Q3 2013

High Level SDSD Test Plan Develop Testing Tools (Done) Conduct Testing (March-May 2013) –Volunteers create test files –Provide files to FDA –FDA reviews format/content FDA will analyze the results –Test Report –Identify any changes to standard, I.G., vocabulary, xForm

What happens after Testing? Make needed changes to artifacts Normative SDSD ballot Finalize I.G. Operational Pilot Policy Decision: Implement Yes/No??

Phase 3: Current Status Subject Data using CDA R2 Testing not yet started Draft CDA Implementation Guides for clinical (SDTM) and nonclinical (SEND) data complete; to be shared Nov 2012 with Stage 2 team for comment –Support for “round” multi-relational data –“Forward compatibility” – I.G. can accommodate new SDTM content as it is developed –I.G.s written using VA’s Model Driven Health Tool (MDHT): Conformance rules part of the I.G.